Malaria Prevention

[1]  D. Freedman.  Tafenoquine: integrating a new drug for malaria prophylaxis into travel medicine practice. , 2019, Journal of travel medicine.

[2]  J. Baird.  Tafenoquine for travelers' malaria: evidence, rationale and recommendations , 2018, Journal of travel medicine.

[3]  P. Kremsner,et al.  Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis , 2017, The Journal of antimicrobial chemotherapy.

[4]  B. Genton,et al.  Malaria prevention strategies and recommendations, from chemoprophylaxis to stand-by emergency treatment: a 10-year prospective study in a Swiss Travel Clinic , 2017, Journal of travel medicine.

[5]  Eli Schwartz,et al.  Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. , 2016, Journal of travel medicine.

[6]  W. Mccarthy,et al.  Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries , 2015, Malaria Journal.

[7]  B. Pradines,et al.  Tetracyclines in malaria , 2015, Malaria Journal.

[8]  J. Logan,et al.  Mosquito repellents for travellers , 2015, BMJ : British Medical Journal.

[9]  P. Schlagenhauf,et al.  Risk factors associated with malaria deaths in travellers: a literature review. , 2015, Travel medicine and infectious disease.

[10]  W. Mccarthy,et al.  A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area , 2014, Malaria Journal.

[11]  Mary E. Wilson,et al.  GeoSentinel Surveillance of Illness in Returned Travelers, 2007–2011 , 2013, Annals of Internal Medicine.

[12]  B. Genton,et al.  Malaria prevention in travelers. , 2012, Infectious disease clinics of North America.

[13]  J. Dumler,et al.  Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  A. Magill,et al.  Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis , 2011, The American journal of tropical medicine and hygiene.

[15]  H. Maltezou,et al.  Malaria and travellers visiting friends and relatives. , 2010, Travel medicine and infectious disease.

[16]  S. Moore,et al.  Expert review of the evidence base for arthropod bite avoidance. , 2010, Journal of travel medicine.

[17]  J. Baird,et al.  Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. , 2009, The Lancet. Infectious diseases.

[18]  D. Freedman.  Clinical practice. Malaria prevention in short-term travelers. , 2008, The New England journal of medicine.

[19]  P. Schlagenhauf,et al.  Malaria Chemoprophylaxis: Strategies for Risk Groups , 2008, Clinical Microbiology Reviews.

[20]  Clinton K. Murray,et al.  Update on Rapid Diagnostic Testing for Malaria , 2008, Clinical Microbiology Reviews.

[21]  Mary E. Wilson,et al.  Controversies and misconceptions in malaria chemoprophylaxis for travelers. , 2007, JAMA.

[22]  A. Magill,et al.  Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. , 2006, The American journal of tropical medicine and hygiene.

[23]  G. Krause,et al.  Chemoprophylaxis and Malaria Death Rates , 2006, Emerging infectious diseases.

[24]  K. Leder,et al.  Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers. , 2006, Journal of travel medicine.

[25]  K. Leder,et al.  Malaria in travelers: a review of the GeoSentinel surveillance network. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  E. Ashley,et al.  Malaria and the pregnant traveller. , 2004, Travel medicine and infectious disease.

[27]  R. Price,et al.  The role of standby emergency medication for falciparum malaria: current opinion. , 2004, Travel medicine and infectious disease.

[28]  J. Berman.  Toxicity of commonly-used antimalarial drugs. , 2004, Travel medicine and infectious disease.

[29]  J. Manitta,et al.  Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. , 2006, Journal of travel medicine.

[30]  S. Hoffman,et al.  Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Frame,et al.  No evidence for chloroquine-associated retinopathy among missionaries on long-term malaria chemoprophylaxis. , 1994, The American journal of tropical medicine and hygiene.

[32]  H. Lobel,et al.  Long-term malaria prophylaxis with weekly mefloquine , 1993, The Lancet.